title: Clinical development directions in oncolytic viral therapy.
abstract: Oncolytic virotherapy is an emerging experimental treatment platform for cancer therapy. Oncolytic viruses are replicative-competent viruses that are engineered to replicate selectively in cancer cells with specified oncogenic phenotypes. Multiple DNA and RNA viruses have been clinically tested in a variety of tumors. This review will provide a brief description of these novel anticancer biologics and will summarize the results of clinical investigation. To date oncolytic virotherapy has shown to be safe, and has generated clinical responses in tumors that are resistant to chemotherapy or radiotherapy. The major challenge for researchers is to maximize the efficacy of these viral therapeutics, and to establish stable systemic delivery mechanisms.
authors: Mary Crowley Cancer Research Centers, Dallas, TX 75201, USA.
authors: R M
authors: RM
authors: Eager
authors: J
authors: J
authors: Nemunaitis
mesh_terms: D000256:Adenoviridae / Q000235:genetics; D005818:Genetic Engineering / Q000379:methods*; D006801:Humans; D009369:Neoplasms / Q000628:therapy*; D009522:Newcastle disease virus / Q000235:genetics; D050130:Oncolytic Virotherapy / Q000379:methods* / Q000639:trends*; D012087:Reoviridae / Q000235:genetics; D018139:Simplexvirus / Q000235:genetics; D014616:Vaccinia virus / Q000235:genetics